Pfizer Director of Innovation Policy Diana Pankevich in a recent column published on Clinical Leader looks at some ways organizations can develop more patient-centered methods in the drug development process.
“How can companies build trust with patients?” she writes. “How can they advance their work in ways that meet patients’ expectations? Ways that address patient needs and reflects their priorities. For Pfizer, whose mission is to bring forward breakthroughs that change patients’ lives, one focus is on moving from engagement to co-creation with patients.”
To read the full column on Clinical Leader, click here.